Dennis M. McGrath's Insider Trades & SAST Disclosures
Dennis M. McGrath's most recent trade in Lucid Diagnostics Inc was a trade of 300,000 Common stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Dennis M. McGrath.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lucid Diagnostics Inc | Dennis M. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 300,000 | 1,343,569 | - | 0 | Common stock | |
| Citius Oncology Inc. | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharmaceuticals Inc | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Purchase Common Stock) | |
| Citius Oncology Inc. | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Lucid Diagnostics Inc | Dennis M. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 400,000 | 1,043,569 | - | 0 | Common stock | |
| DarioHealth Corp | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 80,000 | 154,744 (6%) | 3% | 0 | Common Stock | |
| Citius Pharmaceuticals Inc | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 75,000 | 75,000 | - | - | Options to Purchase Common Stock | |
| PAVmed Inc | Dennis M. McGrath | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share. | 28 Mar 2022 | 199,973 | 755,489 (1%) | 0% | 1.2 | 235,968 | Common stock |
| PAVmed Inc | Dennis M. McGrath | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 150,000 | 150,000 | - | - | Employee stock option (right to buy) | |
| Lucid Diagnostics Inc | Dennis M. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 50,000 | 50,000 | - | - | Employee stock option (right to buy) | |
| Lucid Diagnostics Inc | Dennis M. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 60,000 | 624,400 | - | 0 | Common stock | |
| DarioHealth Corp | Dennis M. McGrath | Director | Sale of securities on an exchange or to another person at price $ 17.11 per share. | 26 May 2021 | 45,773 | 51,630 (2%) | 2% | 17.1 | 783,144 | Common Stock |
| DarioHealth Corp | Dennis M. McGrath | Director | Sale of securities on an exchange or to another person at price $ 16.72 per share. | 26 May 2021 | 22,014 | 29,616 (1%) | 0% | 16.7 | 368,039 | Common Stock |
| PAVmed Inc | Dennis M. McGrath | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 150,000 | 955,462 (2%) | 0% | 0 | Common Stock | |
| DarioHealth Corp | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 29,616 | 97,403 | - | 0 | Restricted Stock Units | |
| DarioHealth Corp | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2020 | 2,378 | 67,787 (3%) | 0% | 0 | Common Stock | |
| PAVmed Inc | Dennis M. McGrath | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 250,000 | 791,704 (2%) | 0% | 0 | Common Stock | |
| DarioHealth Corp | Dennis M. McGrath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 2,378 | 65,409 (2%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges